Linda M. Richardson - 01 Sep 2022 Form 4 Insider Report for INTERCEPT PHARMACEUTICALS, INC.

Role
EVP & Chief Commercial Officer
Signature
/s/ Rocco Venezia, as attorney-in-fact
Issuer symbol
N/A
Transactions as of
01 Sep 2022
Net transactions value
-$10,782
Form type
4
Filing time
06 Sep 2022, 16:01:24 UTC
Previous filing
17 Aug 2022
Next filing
03 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICPT Common Stock Tax liability $10,782 -597 -1.8% $18.06 33,077 01 Sep 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person.